Cargando…
Global survey of the immunomodulatory potential of common drugs
Small molecule drugs may complement antibody-based therapies in an immune-oncology setting, yet systematic methods for the identification and characterization of the immunomodulatory properties of these entities are lacking. We surveyed the immumomodulatory potential of 1,402 small chemical molecule...
Autores principales: | Vladimer, Gregory I., Snijder, Berend, Krall, Nikolaus, Bigenzahn, Johannes W., Huber, Kilian V.M., Lardeau, Charles-Hugues, Sanjiv, Kumar, Ringler, Anna, Berglund, Ulrika Warpman, Sabler, Monika, de la Fuente, Oscar Lopez, Knöbl, Paul, Kubicek, Stefan, Helleday, Thomas, Jäger, Ulrich, Superti-Furga, Giulio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438060/ https://www.ncbi.nlm.nih.gov/pubmed/28437395 http://dx.doi.org/10.1038/nchembio.2360 |
Ejemplares similares
-
A time-resolved molecular map of the macrophage response to VSV infection
por: Kandasamy, Richard K, et al.
Publicado: (2016) -
Image-based ex-vivo drug screening for patients with aggressive haematological malignancies: interim results from a single-arm, open-label, pilot study
por: Snijder, Berend, et al.
Publicado: (2017) -
A Conserved Circular Network of Coregulated Lipids Modulates Innate Immune Responses
por: Köberlin, Marielle S., et al.
Publicado: (2015) -
Recent advances in combinatorial drug screening and synergy scoring
por: Pemovska, Tea, et al.
Publicado: (2018) -
Stereospecific targeting of MTH1 by (S)-crizotinib as anticancer strategy
por: Huber, Kilian V. M., et al.
Publicado: (2014)